Archive
e-therapeutics jumps as share overhang created by Woodford’s need to liquidate assets further cleared
A look at some of the biggest risers and fallers in London on Thursday
Company
Allergy Therapeutics PLC
LON:AGY
Allergy Therapeutics PLC is an international commercial biotechnology company, headquartered in the UK, focussed on the treatment and diagnosis of allergic disorders, including aluminium free immunotherapy vaccines that have the potential to cure disease. The company sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional ten countries.
298 stories · page 6 of 15
Allergy Therapeutics jumps as it lifts profit forecasts after multi-million-dollar legal victory
Tight cost control and solid sales growth means this year’s profits will be better than initially expected, while the company has also received US$7.6mln in compensation after a 2016 trial cock-up
Archive
Ted Baker tumbles to seven-year low as HSBC slashes target
A look at the day's major movers, including Ted Baker, IAG, easyJet, Bagir, Blue Prism, EVR, Blackbird, Nu-Oil & Gas, Anglo Asian Mining and Petrel Resources
Archive
Proactive news snapshot: Nu-Oil and Gas, Futura Medical, Anglo Asian Mining …
A glance at some of the day's highlights from the Proactive Investors newswire
Archive
FTSE 100 slips at close as investors brace for US Fed decision
All eyes will be on the statement from Fed rate setters later, especially due to the pressure to lower rates from President Trump
Archive
Proactive news snapshot: WYG, Echo Energy, Collagen Solutions. Bacanora Lithium …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Frontier Smart Technologies soars after rejecting bid approach from Science Group
A look at the day's major movers, including TLOU Energy, Ten Lifestyle, Katoro Gold, Equatorial Palm Oil, Volga Gas, WYG, AB Dynamics and LXI REIT.
Allergy Therapeutics reports positive results from early-stage study of dust mite jab
Not only was Acarovac seen to be safe and well-tolerated in the phase I trial, but the 16 patients taking part also enjoyed a “significant improvement” in their symptoms
Investments and investor services
FTSE 100 closes in the red as trade tensions and Brexit confusion rumble on
The UK index of leading shares closed down nearly 38 points at 7,310
Archive
Proactive news snapshot: Kromek, ITM Power, Rockfire Resources
A glance at some of the day's highlights from the Proactive Investors newswire
Allergy Therapeutics thinks its adjuvant system could be used in fight against cancer
The combination of Allergy’s Microcrystalline Tyrosine (MCT) adjuvant system with virus-like particles proved successful in mice
Archive
Proactive news snapshot: Feedback, BigDish, Scancell, Sirius Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Sirius Minerals blooms after signing agribusiness deal
A look at the day's major movers, including Image Scan, Water Intelligence, Laura Ashley, Gulf Marine, Synectics and Synnovia
Allergy Therapeutics gets regulatory green light for phase III grass pollen trial
The company is aiming for regulatory approvals in both the US and Europe
Archive
FTSE 100 ends lower as US stocks retreat after mixed tech earnings
The FTSE 100 index closed 37.62 points, or 0.5% lower at 7,434.13, albeit above the session low of 7,405.99 as US stocks continued to post big falls on Thursday
Archive
Proactive news snapshot: WideCells Group, Tlou Energy, Oriole Resources, Strategic Minerals …
A glance at some of the day's highlights from the Proactive Investors newswire
Investments and investor services
Defenx on the back foot as it draws down last of its loan facility
A look at the day's major movers, including AssetCo, Restore, Miton, Maintel, Microsaic, Footasylum, TomCo, GoldStone and Bluebird
Allergy Therapeutics surprised by the results of PQ Birch jab trial
The B301 trial was a multi-centre, double-blind, placebo-controlled study designed to test the efficacy in birch-pollen induced seasonal allergic rhinitis
Investments and investor services
FTSE 100 closes higher as Bercow deals blow to May's Brexit plan
Bercow says the government can only bring back the vote if there has been substantial 'change' to the Brexit deal